Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 04.03.2021.

#VaccineHesitancy
#ItsOurShot
#LifeSciences
#COVID19
#NBTintheNews
#genomes
#sequencing
#BlackHistoryMonth
#HealthcareNews
#CreatingPossible

Career And Jobs

@MALifeSciences shared
On Mar 2, 2021
RT @MassBio: #ItsOurShot to address #COVID19 #VaccineHesitancy. That is why MassBio is launching a social media campaign to create a platform for #LifeSciences leaders of color. Learn more & get involved: https://t.co/HthTgpgjLY
Open
#ItsOurShot to Address Vaccine Hesitancy

#ItsOurShot to Address Vaccine Hesitancy

The biotech industry must play a bigger role in combatting COVID-19 vaccine hesitancy.

@NatureBiotech shared
On Mar 3, 2021
Scientists sequence 64 human genomes as new reference for genetic diversity #NBTintheNews via @GENbio https://t.co/JF4olHixxS
Open
Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity

Scientists Sequence 64 Human Genomes as New Reference for Genetic Diversity

New dataset could ultimately be used to to help develop more targeted, personalized treatments and preventative medicine.

@Bio_Careers shared
On Mar 3, 2021
Choosing your career carefully https://t.co/YZQ9UjGvuu
Open
Choosing your career carefully

Choosing your career carefully

Believe it or not, but being a scientist leaves you with quite a few career choices in both science-related and unrelated fields.

@JohnCendpts shared
On Feb 26, 2021
This was an interesting interview: Roivant parlays a $450M chunk of equity in biotech buyout, grabbing a computational group to drive discovery work https://t.co/OnGMYoaohZ
Open
Roivant parlays a $450M chunk of equity in biotech buyout, grabbing a computational group to drive discovery work

Roivant parlays a $450M chunk of equity in biotech buyout, grabbing a computational group to drive discovery work

New Roivant CEO Matt Gline has crafted an all-equity upfront deal to buy out a Boston-based biotech that has been toiling for several years now at building a supercomputing-based ...

@JohnCendpts shared
On Mar 2, 2021
PINK1 AbbVie tees up a biotech buyout after sizing up their Parkinson's drug spun out of Kevan Shokat's lab $ABBV https://t.co/24pS6L6rIL
Open
AbbVie tees up a biotech buyout after sizing up their Parkinson's drug spun out of Kevan Shokat's lab

AbbVie tees up a biotech buyout after sizing up their Parkinson's drug spun out of Kevan Shokat's lab

AbbVie has teed up a small but intriguing biotech buyout after looking over the preclinical work it’s been doing in Parkinson’s disease. The company is called Mitokinin, a Bay Area biotech ...

@GileadSciences shared
On Feb 26, 2021
Gilead is seeking the next generation of Black STEM innovators to make history. An inclusive and diverse workforce will help us create a better, healthier world: https://t.co/SqkMh9EC0T #BlackStemMatters #BlackHistoryMonth #CreatingPossible https://t.co/jYhqs03tL2
Open
@pharminews shared
On Mar 3, 2021
Propanc Biopharma Provides A Shareholder Update for 2021 https://t.co/UFHgFy62pr #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/2UL21c3746
Open
Propanc Biopharma Provides A Shareholder Update for 2021

Propanc Biopharma Provides A Shareholder Update for 2021

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients ...

@Bio_Careers shared
On Mar 3, 2021
Associate Director/Director https://t.co/EtFdIU1yKd
Open
Associate Director/Director

Associate Director/Director

Really happy to have found this forum.  I participated in the old Science Careers forum and got much helpful advise there.  So glad to be here and hope to get some good advise on possible ...